Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
Saved in:
| Title: | Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients? |
|---|---|
| Authors: | See, Sharon |
| Source: | Journal of Family Practice. Oct2000, Vol. 49 Issue 10, p883-884. 2p. |
| Subjects: | Pneumonia, Hospital patients, Lung diseases, Antibacterial agents, Respiratory diseases, Symptoms |
| Abstract: | The article examines the efficacy of azithromycin monotherapy compared to cefuroxime and erythromycin to treat community-acquired pneumonia (CAP) in hospitalized patients. The American Thoracic Society recommends a second- or third-generation cephalosporin with or without a macrolide for empiric treatment of community-acquired pneumonia in hospitalized patients. These guidelines have resulted in better outcomes in patients younger than 60 years but not in older patients. This mulitcenter study reported the results of 145 evaluable hospitalized patients with a primary diagnosis of CAP. The average age of these patients was not stated. Their condition was diagnosed by chest x-ray, with either one or more signs and symptoms consistent with lower respiratory infection or an elevated white blood cell count. This was a prospective randomized unblinded trial comparing the empiric treatment of CAP with 2 regimens. One group of patients received intravenous azithromycin 500 mg daily for 2 to 5 days followed by oral therapy to complete a 7- to 10-day course. |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 3892558 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22See%2C+Sharon%22">See, Sharon</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Family+Practice%22">Journal of Family Practice</searchLink>. Oct2000, Vol. 49 Issue 10, p883-884. 2p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Pneumonia%22">Pneumonia</searchLink><br /><searchLink fieldCode="DE" term="%22Hospital+patients%22">Hospital patients</searchLink><br /><searchLink fieldCode="DE" term="%22Lung+diseases%22">Lung diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Antibacterial+agents%22">Antibacterial agents</searchLink><br /><searchLink fieldCode="DE" term="%22Respiratory+diseases%22">Respiratory diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Symptoms%22">Symptoms</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: The article examines the efficacy of azithromycin monotherapy compared to cefuroxime and erythromycin to treat community-acquired pneumonia (CAP) in hospitalized patients. The American Thoracic Society recommends a second- or third-generation cephalosporin with or without a macrolide for empiric treatment of community-acquired pneumonia in hospitalized patients. These guidelines have resulted in better outcomes in patients younger than 60 years but not in older patients. This mulitcenter study reported the results of 145 evaluable hospitalized patients with a primary diagnosis of CAP. The average age of these patients was not stated. Their condition was diagnosed by chest x-ray, with either one or more signs and symptoms consistent with lower respiratory infection or an elevated white blood cell count. This was a prospective randomized unblinded trial comparing the empiric treatment of CAP with 2 regimens. One group of patients received intravenous azithromycin 500 mg daily for 2 to 5 days followed by oral therapy to complete a 7- to 10-day course. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=3892558 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: 883 Subjects: – SubjectFull: Pneumonia Type: general – SubjectFull: Hospital patients Type: general – SubjectFull: Lung diseases Type: general – SubjectFull: Antibacterial agents Type: general – SubjectFull: Respiratory diseases Type: general – SubjectFull: Symptoms Type: general Titles: – TitleFull: Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: See, Sharon IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: Oct2000 Type: published Y: 2000 Identifiers: – Type: issn-print Value: 00943509 Numbering: – Type: volume Value: 49 – Type: issue Value: 10 Titles: – TitleFull: Journal of Family Practice Type: main |
| ResultId | 1 |
